UnknownN/Aketamine

Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration

NCT ID

NCT05297422

Target Enrollment

81 participants

Start Date

2022-01-20

Est. Completion

2023-06

About This Study

The purpose of this study is to assess Ketamine as an adjuvant to Branchial Plexus Blockade.

Conditions Studied

Branchial Plexus BlockadeAnesthesia

Interventions

•Forearm surgey
•Ropivacaine
•Ketamine

Eligibility

Age:16 Years - 70 Years

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* BMI 20-35
* ASA score I, II, III

Exclusion Criteria:

* Mental disorder
* Peripheral neuropathy
* Severe hepatic or renal disease
* Gastrointestinal bleeding history

Study Locations (1)

National and Kapodistrian University of Athens

Athens, Attica, Greece